drugset / Trial / NCT03566147
Treatment of RP and LCA by Primary RPE Transplantation
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Early Phase I Study of the Safety and Preliminary Efficacy of Human primary Retinal Pigment Epithelial (HuRPE) Cells Subretinal Transplantation in Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) Patients
Timeline
- Start
- 2018-08-01
- Primary completion
- 2019-12-31
- Completion
- 2020-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human primary Retinal Pigment Epithelial (HuRPE) cells | Unknown | 300000 cells | Other |
| Subject | Human primary Retinal Pigment Epithelial (HuRPE) cells | Unknown | 500000 cells | Other |
| Subject | Human primary Retinal Pigment Epithelial (HuRPE) cells | Unknown | 1e+06 cells | Other |